Month: April 2024

Our intervention, initiated at EPI-2 and based on extended single-drug postnatal prophylaxis guided by point-of-care maternal viral load could be an important strategy for paediatric HIV elimination. We did a phase 3, open-label, randomised controlled trial at four health-care facilities Continue reading New publication in Lancet on the results of PROMISE-EPI→

Our study aimed to assess the PMTCT indicators in Burkina Faso and Zambia using a patient-orientated innovative strategy based on the second visit in the Expanded Program on Immunization (EPI-2) visit at 6–8 weeks. The results are published in the journal Continue reading New publication on the results of PROMISE-EPI→